image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

SIGN UP NOW
Primary Recommendation

Concateno - Fast growing drug screening provider eyes more deals

July 2007

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • COT
  • Price:
  • 177.5p
Following our piece on drug screening business Concateno in last month’s issue, we met up with chairman Keith Tozzi and chief executive Fiona Begley and they reinforced our belief that the company has a very bright future ahead. The great thing about Concateno, which provides services to help employers identify staff who abuse alcohol and / or illegal drugs, is that it operates in a niche of the life sciences industry that is growing at a rate of 30% a year. On the back of this and several strategically important acquisitions, house broker Collins Stewart has put out an aggressive set of forecasts, which point to eps nearly quadrupling over the next four years. However, this doesn’t factor in future acquisitions, with ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

Concateno - Fast growing provider of drug screening services (June 2007)
Concateno - New shell from Marwyn Capital (May 2005)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X